Japanese cedar Pollinosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)CAPRAST score against Japanese cedar pollen over class 2 within the last 2 years. 2)Patient whom the nose symptom that was apparent to the cedar pollen scattering period this year developed in. 3)Written informed concent is required.
Exclusion criteria
Exclusion criteria: 1)Patients with mucosal lesion of the nose and eyes. 2)Patients who received steroid injections within 6 months. 3) 4)Patients with respiratory disease such as asthma. 5)Patients with past history of anaphylaxis. 6)Patients who have receiving immunotherapy. 7)Patients who were judged to be unsuitable for patient enrollment by their doctor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptoms score (Nasal) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)Nasal secretion volume 2)Number of sneezing 3)Occurrence time of first nasal symptoms 4)Bitterness of the symptom(VAS) | — |
Countries
Japan
Contacts
Tokyo Reserch Center of Clinical Pharmacology co.,ltd. Customer Relations Dept.